Every inquiry is reviewed by ARI's medical and operations leadership — not a generic intake queue.
Physician-Led Clinical Research Site Network
Clinical trials move faster when the site network is built for execution.
ARI gives sponsors and CROs one operating relationship across research sites in Los Angeles, San Francisco, and Las Vegas. Experienced physician investigators, centralized startup systems, diverse patient access, and deep ophthalmology expertise applied across specialty programs.
Physician-led network
Los Angeles · San Francisco · Las Vegas
Phase I–IV and device capability
Deep ophthalmology bench
Includes recommended sites, patient-access view, investigator availability, and startup considerations.
Principal investigator-led programs with top-enrolling status globally across multiple specialty studies.
Retina, glaucoma, dry eye, and thyroid eye disease depth, with site operations built to carry specialty and device programs broadly.
Clinical focus
Specialty depth where protocols are hardest to execute.
ARI's model is strongest where protocols need specialty investigators, imaging and diagnostics discipline, disease-specific patient access, and multi-visit retention — in ophthalmology and across adjacent specialty programs.
AMD, geographic atrophy, diabetic eye disease, RVO, inherited retinal disease
Experienced investigators and imaging workflows for chronic retina programs, high-touch follow-up, and longitudinal endpoints.
Glaucoma, cornea, dry eye, ocular surface, and device programs
Procedure-aware site operations for visit-heavy protocols, visual function and imaging endpoints, and sponsor documentation standards.
Thyroid eye disease, rare disease, pediatric, and complex interventional studies
Centralized feasibility and referral logic help sponsors understand which sites, markets, and investigators fit first.
Sponsor pathway
Everything your internal team needs to move from first review to intake.
ARI keeps the sponsor path simple so clinical operations, medical, and procurement teams can evaluate the network and hand off without losing momentum.
Review the network footprint
Confirm geography, specialty depth, and patient-access logic across Los Angeles, San Francisco, and Las Vegas.
Open network reviewDownload the sponsor deck
Use the capabilities deck for internal circulation while your team validates fit and timeline assumptions.
Get the deckShare protocol stage and priorities
Send what you have, even early. ARI can review study type, markets, timing, and required procedures.
Start intakeReceive a sponsor-ready readout
ARI returns recommended sites, operational considerations, and next-step follow-up from leadership.
Contact sponsor deskSponsor briefing room
Everything a sponsor team usually needs for the first internal pass.
ARI packages the network story around the questions sponsor teams actually ask first: who owns the relationship, which markets fit, how startup is managed, and what happens after intake.
One sponsor-facing team coordinates every site instead of running parallel feasibility tracks.
Ophthalmology-rooted investigators support rare disease, pediatric, imaging, and device-heavy programs.
Standardized SOPs, training, and documentation keep activation consistent across the network.
Janelle Gonzalez and Daniel Lemor stay on the sponsor path for quick handoff and escalation.
Internal handoff assets
What your team can circulate right now.
- Capabilities deck for medical, clinical ops, and procurement review.
- Network page organized around Los Angeles, San Francisco, and Las Vegas market logic.
- Sponsor intake reviewed directly by ARI's medical and operations leadership.
- Direct sponsor desk contacts for introductions, timing questions, or internal follow-up.
Network footprint
Research sites in Los Angeles, San Francisco, and Las Vegas.
Three major western markets give sponsors concentrated patient access, coordinated through one network intake and one sponsor team.
California
Los Angeles & San Francisco
Major metropolitan research markets with diverse patient populations and strong referral networks across the state.
Los Angeles
San Francisco
Nevada
Las Vegas
A large retirement-age population with high disease prevalence — particularly valuable for age-related conditions and chronic disease programs.
Las Vegas
Single intake, multi-site activation
One feasibility conversation covers every ARI site. No redundant sponsor meetings or duplicated startup processes.
30,000+ direct. 350,000+ affiliated.
Internal database of 30,000+ patients with access to 350,000+ through affiliated networks and referral systems.
Phase I–IV. Interventional. Device.
Full-phase capability including complex interventional, rare disease, pediatric, and device trials.
